Patrice P. Cacoub
Expertise in
42
conditions

Patrice P. Cacoub

APHP Pitié Salpétrière
Paris, FR 
Expertise in
42
conditions
APHP Pitié Salpétrière
Paris, FR 

Overview

Patrice Cacoub practices practicing medicine in Paris, France.

Mr. Cacoub is highly rated in 42 conditions, according to our data. His clinical expertise encompasses Cryoglobulinemia, Vasculitis, Takayasu Arteritis, Hepatitis C, and Vitrectomy.

He is actively involved in clinical research, co-authoring 417 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

APHP Pitié Salpétrière
Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
Real-life Evaluation of the Efficacy of Pre-exposure Treatment With Hydroxy-Chloroquine on the Risk and Severity of COVID-19 Infection in Patients Receiving Long-term Treatment for Systemic Lupus Erythematosus and/or Gougerot's Disease
Enrollment Status: Completed
Publish Date: August 10, 2026
Intervention Type: Diagnostic test, Other
Study Phase: Not Applicable
Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach
Induction of Regulatory t Cells by Low Dose IL2 in Autoimmune and Inflammatory Diseases: a Transnosographic Approach
Enrollment Status: Completed
Publish Date: July 20, 2021
Intervention Type: Drug
Study Drug: IL-2
Study Phase: Phase 2
View 1 Less Clinical Trial

417 Total Publications

Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
Journal: Circulation
Published: August 29, 2026

Frequently Asked Questions about Patrice P. Cacoub

Is Patrice P. Cacoub a top-rated expert for Cryoglobulinemia?

MediFind is an objective health platform that identifies experts based on real-world data. Patrice P. Cacoub is classified as an Elite expert for Cryoglobulinemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Patrice P. Cacoub participate in research or clinical trials?

Yes. Patrice P. Cacoub has published 417 articles and abstracts on conditions like Cryoglobulinemia. You can view a list of Patrice P. Cacoub's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Cacoub's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 28 Advanced Conditions
View All 67 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile